Nathan Canen

General seminars
amse seminar

Nathan Canen

University of Warwick
Innovation Adoption by Committee: Evaluating Decision-Making in the FDA
Joint with
Mathias Iaryczower

IBD Amphi

Îlot Bernard du Bois - Amphithéâtre

5-9 boulevard Maurice Bourdet
13001 Marseille

Monday, April 15 2024| 11:30am to 12:45pm

Nicolas Clootens: nicolas.clootens[at]
Romain Ferrali: romain.ferrali[at]


The FDA is responsible for the approval of new drugs, biological products and medical devices in the United States. As part of the approval process, the FDA relies on advisory committees, which provide independent advice from outside experts. In this paper, we empirically study the process of collective learning and voting in FDA advisory committees, using data from transcripts of all meetings conducted between 2007 and 2020. To do this, we structurally estimate a dynamic model in which committee members with heterogeneous preferences and priors hear evidence presented to them, and strategically decide when to stop gathering information and vote. We use our estimates to quantify the probability of correct recommendations by the advisory panels, and compute counterfactual policy experiments to evaluate institutional changes to the decision-making process ruling approval of new products by the FDA.

More information